-+ 0.00%
-+ 0.00%
-+ 0.00%

Wolfe Research Maintains Outperform on Merck & Co, Raises Price Target to $180

Benzinga·08/25/2026 15:27:34
语音播报
Wolfe Research analyst Alexandria Hammond maintains Merck & Co (NYSE:MRK) with a Outperform and raises the price target from $155 to $180.